Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.06. | Fangdd Network Group Ltd: FangDD Announces Termination Plan for Its ADR Facility, and the Plan to Hold an Extraordinary General Meeting of Shareholders | 80 | GlobeNewswire (Europe) | SHENZHEN, China, June 03, 2024 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (Nasdaq: DUO) ("FangDD" or the "Company") today announced that the Company and The Bank of New York Mellon intend to terminate... ► Artikel lesen | |
03.06. | Ekobot finalises the sale of the Company's business | 116 | GlobeNewswire (Europe) | Ekobot AB (publ) ("Ekobot" or the "Company") announces today that the Company has completed the sale to HH Agriculture Investments B.V. (the "Buyer") of the Company's business. The Buyer has acceded... ► Artikel lesen | |
03.06. | National Bankshares, Inc. Completes Acquisition of Frontier Community Bank | 210 | GlobeNewswire (Europe) | BLACKSBURG, Va., June 03, 2024 (GLOBE NEWSWIRE) -- National Bankshares, Inc. (Nasdaq: NKSH - "National Bankshares" or the "Company"), the holding company for The National Bank of Blacksburg ("National... ► Artikel lesen | |
03.06. | Canadian GoldCamps Corp.: Canadian GoldCamps Enters into Definitive Agreement to Acquire 70% interest in Murphy Lake Property located in the Athabasca Basin, Saskatchewan | 154 | GlobeNewswire (Europe) | VANCOUVER, British Columbia and TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Canadian GoldCamps Corp. ("Canadian GoldCamps", or the "Company") (CSE: CAMP) (FSE: A68) (OTC: SMATF) announces that further... ► Artikel lesen | |
03.06. | American Oncology Network Appoints David Afshar as Chief Financial and Operating Officer | 192 | GlobeNewswire (Europe) | FORT MYERS, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), one of the nation's fastest-growing community oncology networks, today announced the appointment... ► Artikel lesen | |
03.06. | Ingersoll Rand Closes on ILC Dover and Announces Acquisition of Three Additional Companies | 249 | GlobeNewswire (Europe) | Extends portfolio in sustainable end markets, including life sciences, food and beverage, medical, and wastewater treatmentDemonstrates company's commitment to capital allocation and achievement of... ► Artikel lesen | |
03.06. | Zapata Computing, Inc.: Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 173 | GlobeNewswire (Europe) | BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Zapata Computing Holdings Inc. ("Zapata AI" or the "Company") (Nasdaq: ZPTA), the Industrial Generative AI company, today announced that the Compensation... ► Artikel lesen | |
03.06. | Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | 122 | GlobeNewswire (Europe) | FOSTER CITY, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small... ► Artikel lesen | |
03.06. | Structure Therapeutics Inc.: Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants | 174 | GlobeNewswire (Europe) | SAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen | |
03.06. | Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | 81 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) ("Biomea" or the "Company"), a clinical stage biopharmaceutical company focused on the discovery and development... ► Artikel lesen | |
03.06. | Safe Bulkers, Inc. Announces Agreement for the Acquisition of One Japanese Kamsarmax Class Dry-bulk Vessel | 143 | GlobeNewswire (Europe) | MONACO, June 03, 2024 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the Company) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that it has entered into... ► Artikel lesen | |
03.06. | GitLab Inc.: GitLab Reports First Quarter Fiscal Year 2025 Financial Results | 137 | GlobeNewswire (Europe) | First Quarter Fiscal Year 2025 Highlights: Total revenue of $169.2 million, up 33% year-over-yearSignificant year-over-year GAAP and Non-GAAP operating margin expansionOperating cash flow of $38.1... ► Artikel lesen | |
03.06. | Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination | 41 | GlobeNewswire (Europe) | New York, June 03, 2024 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) ("KRNL" or the "Company"), a special purpose acquisition company, announced today that it has elected... ► Artikel lesen | |
03.06. | Lavoro Limited: Lavoro Reports Fiscal Third Quarter 2024 Earnings Results | 442 | GlobeNewswire (Europe) | 3Q24 revenue grew 6% to $514.2 million. Growth was driven by continued market share gains and volume growth, which mitigated ongoing deflation in input prices throughout Brazil and Colombia.Gross... ► Artikel lesen | |
03.06. | X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 80 | GlobeNewswire (Europe) | BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective... ► Artikel lesen | |
03.06. | Dave Inc.: Dave Extends its Partnership with Drew League, LA's Pro-Am Basketball League | 112 | GlobeNewswire (Europe) | LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- Dave (NASDAQ: DAVE), one of the nation's leading neobanks, announced an extension of its official partnership with the Drew League, Los Angeles' premiere... ► Artikel lesen | |
03.06. | FibroGen, Inc.: FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen's Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO in Upcoming Clinical Trials | 144 | GlobeNewswire (Europe) | FibroGen to evaluate FG-3165, an anti-galectin 9 (Gal9) monoclonal antibody (mAb), as monotherapy treatment as well as in combination with LIBTAYO® in patients with select solid tumorsFibroGen to... ► Artikel lesen | |
03.06. | Spero Therapeutics, Inc.: Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 141 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments... ► Artikel lesen | |
03.06. | FibroGen, Inc.: FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors | 230 | GlobeNewswire (Europe) | The safety and efficacy of FG-3165 will be evaluated in a Phase 1 trial in select solid tumorsPlan to begin enrollment in 2H 2024 SAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:... ► Artikel lesen | |
03.06. | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024 | 111 | GlobeNewswire (Europe) | - Participants from the completed Phase 2 hypothalamic obesity trial reported positive changes in sleep, energy levels during setmelanotide therapy in qualitative interviews - - Separate analysis... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 2.907 |
EVOTEC | 2.155 |
TUI | 1.831 |
BAYER | 1.784 |
NVIDIA | 1.666 |
NEL | 1.267 |
RENK GROUP | 1.133 |
RHEINMETALL | 1.038 |
TESLA | 876 |
PALANTIR TECHNOLOGIES | 822 |
DEUTSCHE BANK | 768 |
VOLKSWAGEN | 745 |
MICROSTRATEGY | 711 |
BYD | 694 |
PLUG POWER | 661 |
COMMERZBANK | 651 |
BASF | 630 |
JINKOSOLAR | 612 |
MERCEDES-BENZ | 592 |
AMAZON | 572 |
DEUTSCHE TELEKOM | 551 |
INTEL | 548 |
BMW | 542 |
ALLIANZ | 535 |
THYSSENKRUPP | 533 |